Goldman Sachs raised the firm’s price target on Oracle (ORCL) to $195 from $145 and keeps a Neutral rating on the shares. The company’s revenue and operating margins for Q4 topped estimates, but while its aggressive investment in CapEx is a welcome evidence of strong demand, the firm also questions whether the $25B in FY26 will be enough, noting that the ramping depreciation may constrain potential earnings power over the mid-term, especially if revenue growth targets prove aspirational, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue